For many hospitals and their physician staff, their current glycemic management practices differ from what is overwhelmingly recommended by experts and relevant specialty societies. As a result, they are missing an opportunity to improve the quality, safety, and cost of care for their patients with diabetes and hyperglycemia, which commonly represent more than 25% of their inpatient population. Hospitals that transition from sliding-scale insulin regimens to consistent use of basal-bolus-correction protocols are seeing reductions in hyperglycemia, hypoglycemia and costs. Making this shift more effective and efficient is the use of computerized insulin-dosing algorithms that can support dedicated staff using a systematic approach.

In this webinar, Laurel Fuqua, Monarch’s EVP and Chief Clinical Officer, discusses the current glucose management environment and guest presenter,  Dr. Thomas Garthwaite, Vice President for Diabetes Care at the Healthcare Corporation of America (HCA), shares HCA’s experience in developing and launching a glycemic optimization program using EndoTool IV and SubQ.

Watch the webinar to learn:

  • The importance of adopting inpatient basal/bolus subcutaneous insulin
  • Best practices for managing diabetes and hyperglycemia in the hospital setting
  • Benefits of using an electronic glucose management system (eGMS) in making the transition away from sliding scale
  • First-hand experience, results, and advice in implementing and optimizing EndoTool SubQ


Thomas L. Garthwaite, MD
Vice President for Diabetes Care & Medical Director for Employee Health
Hospital Corporation of America (HCA)

Laurel Fuqua, RN, MSN

Executive VP & Chief Clinical Officer
Monarch Medical Technologies